Letermovir Use in Heart Transplant Recipients

NCT04904614 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Disease
Cytomegalovirus Infections
Heart Transplant Infection
Antiviral Toxicity
Neutropenia

Interventions

DRUG: Letermovir

Sponsor

Tufts Medical Center

Collaborators

[object Object]